October 25, 2017 — Lawmakers in the European Parliament are demanding a 5-year phase-out of Monsanto’s weed-killer Roundup (glyphosate) by 2022.
France and other member-nations of the European Union (EU) said they would not vote to re-approve glyphosate for another 10 years. In response, the European Commission has abandoned the proposal.
The debate about the future of Roundup has been raging for 2 years, ever since the International Agency for Research on Cancer (IARC) announced that it would re-classify glyphosate as a “probable human carcinogen” based on studies linking it to non-Hodgkin’s lymphoma.
Lawmakers from 28 nations in the EU were supposed to meet to discuss whether to extend glyphosate’s license for another 10 years. Instead, the European Parliament voted 355 to 204 in favor of a resolution that will urge the European Commission to phase out glyphosate throughout the EU by mid-December 2022 to 2025.
A spokesman for the European Commission said:
“The direction given is to strive to reach between 5 and 7 years, taking into account the risk assessment made by the European Parliament in today’s vote.”
The Parliament also asked the European Commission and member-nations of the EU to ban glyphosate sales and use in backyards, home gardens, public areas, and farms unless there is no other agricultural alternative for biological pest-control systems.
Do I have a Roundup Lawsuit?
The Schmidt Firm, PLLC is currently accepting Roundup induced injury cases in all 50 states. If you or somebody you know has been diagnosed with non-Hodgkin’s lymphoma, you should contact our lawyers immediately for a free case consultation. Please use the form below to contact our Toxic Chemical Exposure Litigation Group or call toll free 24 hours a day at (866) 920-0753.
Attention Lawyers: We consider a referral from another law firm to be one of the greatest compliments. If your firm is interested in referring us a case or for us to send you a list of previous award judgments and/or average referral fees, please visit the Lawyer Referral section of our website.